Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ultrient is a health and wellness company that specializes in high-bioavailability nutritional supplements using advanced delivery technologies. The company is best known for its application of Liposomal Encapsulation Technology (LET), which is designed to protect nutrients from degradation in the digestive system and enhance their absorption into the bloodstream and cells. Ultrient's product portfolio primarily focuses on essential vitamins and antioxidants, such as Vitamin C and Glutathione, marketed under the Ultrient brand. By leveraging pharmaceutical-grade delivery mechanisms for over-the-counter supplements, the company aims to provide clinical-strength nutritional support for immune health and cellular function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ultrient.